On 24June2024, Shanghai Fosun Pharmaceutical (Group) Co., Ltd.(“Fosun Pharma”; stock code: 600196. SH, 02196. HK) announced its plan to privatise its subsidiary, Shanghai Henlius Biotech, Inc. (“Henlius”; stock code: 02696.HK), by way of merger by absorption.The cash consideration for this merger is HKD24.6 per share, with a premium of approximately 36.67% o

The Fosun ESG Ambassador Week 2024 has recently concluded. The event gathered ESG ambassadors from Fosun's global member companies in Hong Kong to showcase their sustainability initiatives and achievements. The ESG ambassadors engaged in in-depth discussions with local charitable organizations and sustainability teams of financial institutions on topics such as ESG management&

TAICANG, China, June 18, 2024 -- On June 18, the signing ceremony for the Taicang Alps Resort Phase II project, a one-stop ice and snow-themed urban resort destination under Fosun Tourism Group (Stock code: 01992.HK), was grandly held at Club Med Urban Oasis Taicang Resort. The Phase II project, with a total investment exceeding RMB5 billion, will b

(14 June 2024, Shanghai) Over 40 guests, including 10 ambassadors to China, 8 consuls general and other senior diplomats from 26 countries, visited Fosun. The delegation toured along the Grand Yuyuan. From the intangible cultural heritage of the Old City of Shanghai to the vibrant modernity of the Bund, they gained a deep appreciation for how Shanghai has preserve

(12 June 2024) Finloop Finance Technology Holding Limited (“Finloop”), a leading digital intelligent wealth management platform independently incubated by Fosun Wealth International Holdings Limited (“Fosun Wealth”), a subsidiary of Fosun International (00656.HK), announced today that it has entered into strategic cooperation agreements with multiple leading fintech companies&#

The most authoritative corporate governance magazine in the Asia Pacific region, Corporate Governance Asia, has recently presented the 14th Asian Excellence Award. Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International, were awarded Asia’s Best CEO by the magazine.Corporate Governance Asiapointed out that, in 2023, despite

·HANQUYOU is poised to be the first Chinese monoclonal antibody to enter the Middle Eastern market, further expanding its global presence.·HANQUYOU was approved in more than 40 countries and regions around the world.·With the first shipment to the Middle East, Henlius has realized commercialized supply across China, Europe, Southeast Asia, Latin America,&#

On 4 June 2024,Lisbon, Portugal, Chinese Minister of Commerce Wang Wentao chaired a roundtable with representatives from Chinese enterprises operating in Portugal. Representatives from Chinese enterprises engaged in sectors such as energy, finance, construction, and telecommunications in Portugal attended the roundtable, during which they shared the deve

Fosun International receives Sustainable Asia Award and Best Corporate Communications AwardOn 31 May 2024, themagazineCorporate Governance Asiapresented the 14th Asian Excellence Award. Chen Qiyu and Xu Xiaoliang, Executive Directors and Co-CEOs of Fosun International Limited (“Fosun International”or “Fosun”or the “Group”) (HKEX stock code: 00656) were both